Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rutgers

Showing results (771-780 of 982) with videos related to

Pageof 99
Sort By:
Cancer|April 15, 2006
Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predispositionMieke Kriege, Cecile T M Brekelmans, Carla Boetes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trialG Viale, L Slaets, J Bogaerts, et al.
Therapeutic Advances in Neurological Disorders|November 1, 2024
Therapeutic effect of an inhaled levodopa dry powder formulation on off episodes in patients with Parkinson's diseaseLara de Jong, Marianne Luinstra, Angela Francesca Aalbers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2018
Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma <i>In Situ</i>-A Nested Case-Control StudyLindy L Visser, Lotte E Elshof, Michael Schaapveld, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 12, 2013
First clinical experience with a dedicated PET for hanging breast molecular imagingB B Koolen, T S Aukema, A J González Martínez, et al.
International Journal of Cancer|March 31, 2015
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2015
Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatmentM van der Heiden-van der Loo, L de Munck, G S Sonke, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)A C Voogd, J L Peterse, M A Crommelin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 10, 2013
Sequential (18)F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapyBas B Koolen, Kenneth E Pengel, Jelle Wesseling, et al.
Breast (Edinburgh, Scotland)|July 27, 2025
Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication modelEllen G Engelhardt, Mary Ann E Binuya, Paul D P Pharoah, et al.
Pageof 99

Showing results (771-780 of 982) with videos related to

Sort By:
Pageof 99
Cancer|April 15, 2006
Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predispositionMieke Kriege, Cecile T M Brekelmans, Carla Boetes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trialG Viale, L Slaets, J Bogaerts, et al.
Therapeutic Advances in Neurological Disorders|November 1, 2024
Therapeutic effect of an inhaled levodopa dry powder formulation on off episodes in patients with Parkinson's diseaseLara de Jong, Marianne Luinstra, Angela Francesca Aalbers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2018
Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma <i>In Situ</i>-A Nested Case-Control StudyLindy L Visser, Lotte E Elshof, Michael Schaapveld, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 12, 2013
First clinical experience with a dedicated PET for hanging breast molecular imagingB B Koolen, T S Aukema, A J González Martínez, et al.
International Journal of Cancer|March 31, 2015
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2015
Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatmentM van der Heiden-van der Loo, L de Munck, G S Sonke, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)A C Voogd, J L Peterse, M A Crommelin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 10, 2013
Sequential (18)F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapyBas B Koolen, Kenneth E Pengel, Jelle Wesseling, et al.
Breast (Edinburgh, Scotland)|July 27, 2025
Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication modelEllen G Engelhardt, Mary Ann E Binuya, Paul D P Pharoah, et al.
Pageof 99